Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • My watchlists
  • Help
  • Contact us

Cambridge Cognition Holdings plc (COG) Ordinary 1p

Sell:150.00p Buy:155.00p 0 Change: 11.50p (7.01%)
Market closed |  Prices as at close on 24 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:150.00p
Buy:155.00p
Change: 11.50p (7.01%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 24 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:150.00p
Buy:155.00p
Change: 11.50p (7.01%)
Market closed |  Prices as at close on 24 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Cambridge Cognition Holdings plc and its subsidiaries develop and commercialize computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company's segments include Pharmaceutical Clinical Trials, Academic Research and Healthcare Technology. The Pharmaceutical Clinical Trials segment includes products and services for use in regulated pharmaceutical clinical trials. The Academic Research segment includes cognitive test products for researchers working in a non-regulated environment, typically in academia. The Healthcare Technology segment includes medical software for use in healthcare delivery settings. The Company is a provider of validated touchscreen cognitive assessments for clinical trials. The Company's product, CANTAB Mobile is a Class II medical device, used to identify patients exhibiting the early signs of Alzheimer's disease. It also offers Cantab Insight for dementia assessment in secondary care.

Contact details

Address:
Tunbridge Court
Tunbridge Lane, Bottisham
CAMBRIDGE
CB25 9TU
United Kingdom
Telephone:
+ (0)
Website:
www.cambridgecognition.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 21 September 2021 21/09/21
Trading Announcement 03 August 2021 03/08/21
AGM 27 May 2021 27/05/21
Annual report 05 May 2021 05/05/21
Final results 23 March 2021 23/03/21
Trading Announcement 19 January 2021 19/01/21

General stock information

EPIC:
COG
ISIN:
GB00B8DV9647
Market cap:
£47.54 million
Shares in issue:
31.17 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Matthew Stork
    Chief Executive Officer, Executive Director
  • Michael Holton
    Chief Financial Officer, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.